You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MLN0128

Showing 1 - 25 of 30
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Soft-tissue Sarcoma Trial in Philadelphia (TAK-228)

Terminated
Has Results
  • Soft-tissue Sarcoma
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Sep 19, 2022

Metastatic Breast Cancer, Solid Tumors Trial in Aurora (Alisertib, MLN0128)

Completed
Has Results
  • Metastatic Breast Cancer
  • Solid Tumors
  • Aurora, Colorado
    University of Colorado Cancer Center
May 17, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial in Houston (Laboratory

Completed
  • Advanced Malignant Solid Neoplasm
  • +3 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 21, 2022

Leptomeningeal Tumor, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Tumor in the Brain Trial in United States

Recruiting
  • Leptomeningeal Neoplasm
  • +6 more
  • Duarte, California
  • +6 more
Dec 29, 2022

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage III Lung Non-Small Cell Cancer AJCC v7

Active, not recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +5 more
  • Laboratory Biomarker Analysis
  • +3 more
  • New Haven, Connecticut
  • +4 more
Jan 27, 2023

Anaplastic Thyroid Cancer, Thyroid Cancer Trial in Newport Beach, Boston, Ann Arbor (MLN0128)

Active, not recruiting
  • Anaplastic Thyroid Cancer
  • Thyroid Cancer
  • MLN0128
  • Newport Beach, California
  • +2 more
Feb 18, 2022

Recurrent Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8 Trial in Houston

Active, not recruiting
  • Recurrent Lung Non-Small Cell Carcinoma
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 31, 2022

Recurrent Lung Squamous Cell Carcinoma, Stage IV Lung Squamous Cell Carcinoma AJCC v7 Trial in United States (Laboratory

Completed
Has Results
  • Recurrent Lung Squamous Cell Carcinoma
  • Stage IV Lung Squamous Cell Carcinoma AJCC v7
  • Laboratory Biomarker Analysis
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Mar 16, 2022

Clear-cell Metastatic Renal Cell Carcinoma Trial in Worldwide (Everolimus, MLN0128, MLN1117)

Completed
Has Results
  • Clear-cell Metastatic Renal Cell Carcinoma
  • Los Angeles, California
  • +35 more
Nov 18, 2021

Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 Trial (Nivolumab,

Withdrawn
  • Lung Non-Small Cell Carcinoma
  • +12 more
  • (no location specified)
May 24, 2022

Merkel Cell Carcinoma Trial in Boston (MLN0128)

Completed
Has Results
  • Merkel Cell Carcinoma
  • MLN0128
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Dec 3, 2020

Advanced Solid Tumor Trial in Sioux Falls (paclitaxel, TAK-228, TAK-117)

Active, not recruiting
  • Advanced Solid Tumor
  • Sioux Falls, South Dakota
    Avera Cancer Institute
Aug 24, 2021

Estrogen Receptor Positive Breast Cancer Trial in Houston, Sugar Land (TAK-228, Tamoxifen)

Completed
Has Results
  • Estrogen Receptor Positive Breast Cancer
  • Houston, Texas
  • +2 more
Aug 27, 2021

Endometrial Tumors Trial in Worldwide (Paclitaxel, Sapanisertib, MLN1117)

Completed
Has Results
  • Endometrial Neoplasms
  • Birmingham, Alabama
  • +77 more
Oct 28, 2021

Advanced Solid Tumors Trial in United States (Sapanisertib)

Completed
Has Results
  • Advanced Solid Tumors
  • Sarasota, Florida
  • +4 more
Feb 18, 2020

Metastatic Castration-Resistant Prostate Cancer Trial in New York (MLN0128)

Completed
Has Results
  • Metastatic Castration-Resistant Prostate Cancer
  • MLN0128
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 13, 2019

Non-hematologic Malignancy Trial in United States (Sapanisertib, Paclitaxel)

Completed
Has Results
  • Non-hematologic Malignancy
  • Scottsdale, Arizona
  • +4 more
Feb 14, 2020

Advanced Solid Malignancies Trial in Spain, United States (MLN0128)

Completed
Has Results
  • Advanced Solid Malignancies
  • MLN0128
  • Scottsdale, Arizona
  • +15 more
Mar 18, 2020

Advanced Nonhematologic Malignancies Trial in Worldwide (MLN2480, MLN0128, Alisertib)

Completed
Has Results
  • Advanced Nonhematologic Malignancies
  • Boston, Massachusetts
  • +13 more
Feb 11, 2020

Lymphoma Trial in Houston (TAK228, Blood Sugar Testing)

Terminated
Has Results
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 3, 2020

Breast Cancer Trial in Belgium, France, United States (Sapanisertib, Fulvestrant, Exemestane)

Completed
Has Results
  • Breast Cancer
  • Los Angeles, California
  • +39 more
Dec 16, 2020

Advanced Nonhematologic Malignancies Trial in Spain, United Kingdom, United States (TAK-228, TAK-117)

Completed
Has Results
  • Advanced Nonhematologic Malignancies
  • Boston, Massachusetts
  • +4 more
Oct 7, 2019

Advanced Solid Malignancies, Hematologic Malignancies Trial in Fort Myers, Oklahoma City, Nashville (MLN0128, paclitaxel,

Completed
Has Results
  • Advanced Solid Malignancies
  • Hematologic Malignancies
  • MLN0128
  • +2 more
  • Fort Myers, Florida
  • +2 more
Jun 28, 2019

Breast Tumors Trial in Spain, United States (Fulvestrant, Sapanisertib)

Completed
Has Results
  • Breast Neoplasms
  • Mobile, Alabama
  • +52 more
Nov 20, 2020

High Grade Sarcoma, Metastatic Leiomyosarcoma, Metastatic Malignant Peripheral Nerve Sheath Tumor Trial in United States

Terminated
Has Results
  • High Grade Sarcoma
  • +18 more
  • Birmingham, Alabama
  • +459 more
Jul 27, 2022